Cargando…
Aclidinium inhibits human lung fibroblast to myofibroblast transition
BACKGROUND: Fibroblast to myofibroblast transition is believed to contribute to airway remodelling in lung diseases such as asthma and chronic obstructive pulmonary disease. This study examines the role of aclidinium, a new long-acting muscarinic antagonist, on human fibroblast to myofibroblast tran...
Autores principales: | Milara, Javier, Serrano, Adela, Peiró, Teresa, Gavaldà, Amadeu, Miralpeix, Montserrat, Morcillo, Esteban Jesús, Cortijo, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282044/ https://www.ncbi.nlm.nih.gov/pubmed/21957094 http://dx.doi.org/10.1136/thoraxjnl-2011-200376 |
Ejemplares similares
-
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016) -
Risk and temporal order of disease diagnosis of comorbidities in patients with COPD: a population health perspective
por: Tényi, Ákos, et al.
Publicado: (2018) -
Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008) -
Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012) -
Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
por: Lewis, Amy, et al.
Publicado: (2011)